KR100333039B1 - Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom - Google Patents
Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom Download PDFInfo
- Publication number
- KR100333039B1 KR100333039B1 KR1019990027196A KR19990027196A KR100333039B1 KR 100333039 B1 KR100333039 B1 KR 100333039B1 KR 1019990027196 A KR1019990027196 A KR 1019990027196A KR 19990027196 A KR19990027196 A KR 19990027196A KR 100333039 B1 KR100333039 B1 KR 100333039B1
- Authority
- KR
- South Korea
- Prior art keywords
- promicromonospora
- antibiotics
- genus
- production
- antagonistic
- Prior art date
Links
- 230000003042 antagnostic effect Effects 0.000 title claims abstract description 56
- 230000000843 anti-fungal effect Effects 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 22
- 229940121375 antifungal agent Drugs 0.000 title claims abstract description 21
- 230000003115 biocidal effect Effects 0.000 title claims description 17
- 241000082861 Promicromonospora sp. Species 0.000 title abstract description 8
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 41
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 39
- 241000157932 Promicromonospora Species 0.000 claims abstract description 28
- 102000012286 Chitinases Human genes 0.000 claims abstract description 21
- 108010022172 Chitinases Proteins 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000013587 production medium Substances 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 2
- 239000002689 soil Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 241000223221 Fusarium oxysporum Species 0.000 abstract description 9
- 241000223600 Alternaria Species 0.000 abstract description 6
- 235000002566 Capsicum Nutrition 0.000 abstract description 4
- 241000427940 Fusarium solani Species 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 241001446247 uncultured actinomycete Species 0.000 abstract description 4
- 239000006002 Pepper Substances 0.000 abstract description 3
- 241000233616 Phytophthora capsici Species 0.000 abstract description 3
- 235000016761 Piper aduncum Nutrition 0.000 abstract description 3
- 235000017804 Piper guineense Nutrition 0.000 abstract description 3
- 235000008184 Piper nigrum Nutrition 0.000 abstract description 3
- 230000003032 phytopathogenic effect Effects 0.000 abstract description 3
- 125000002723 alicyclic group Chemical group 0.000 abstract description 2
- 241000722363 Piper Species 0.000 abstract 2
- 241000412366 Alternaria mali Species 0.000 abstract 1
- 241000186361 Actinobacteria <class> Species 0.000 description 32
- 230000012010 growth Effects 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 18
- 239000002609 medium Substances 0.000 description 13
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- 239000005557 antagonist Substances 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 229920002101 Chitin Polymers 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 241000187747 Streptomyces Species 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000223218 Fusarium Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000000443 biocontrol Effects 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 4
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- 101100397226 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp4 gene Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 244000053095 fungal pathogen Species 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241001529387 Colletotrichum gloeosporioides Species 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 101150045440 ISP1 gene Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 101100353471 Mus musculus Prss28 gene Proteins 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000233614 Phytophthora Species 0.000 description 2
- 101100046603 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TOM6 gene Proteins 0.000 description 2
- 101100509103 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ish1 gene Proteins 0.000 description 2
- 101100397228 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp6 gene Proteins 0.000 description 2
- 101100397229 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp7 gene Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000019086 sulfide ion homeostasis Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 241001633583 Adenophora Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 101000610620 Homo sapiens Putative serine protease 29 Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000544912 Melanoides Species 0.000 description 1
- 241000187708 Micromonospora Species 0.000 description 1
- KWQDIZKBVFTDPB-OVVSMXPMSA-N NC(CCC(=O)O)(CCC(=O)O)N.N[C@@H](CCC[C@@H](N)C(=O)O)C(=O)O Chemical compound NC(CCC(=O)O)(CCC(=O)O)N.N[C@@H](CCC[C@@H](N)C(=O)O)C(=O)O KWQDIZKBVFTDPB-OVVSMXPMSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 102100040345 Putative serine protease 29 Human genes 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000918584 Pythium ultimum Species 0.000 description 1
- 241000684075 Rhizoctonia sp. Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100397225 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp3 gene Proteins 0.000 description 1
- 101100397227 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp5 gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- 239000000589 Siderophore Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000873576 Stemphylium sp. Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000853 biopesticidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 210000001654 germ layer Anatomy 0.000 description 1
- -1 glucanase Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000006343 isp 5 medium Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000011140 membrane chromatography Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)(기탁번호 KCTC8946P) 및 이를 이용한 항진균성 항생물질 생산방법에 관한 것으로 키틴나아제와 항생물질을 동시에 생산하므로써 식물병원성 진균인 푸사리움 솔라니(Fusarium solani), 푸사리움 옥시스포룸(Fusarium oxysporum), 얼터나리아 마리(Alternaria mali), 파이토프토라 캡시씨(Phytophthora capsici), 얼터나리아 키키(Alternaria kiki)를 강력하게 저해하는 프로마이크로모노스포라 속 KH-28을 저병해 경작지 토양으로부터 분리하여 제공하는 효과가 있고 이 균주는 pH 7.0, 온도 30℃에서 5일간 배양했을 경우 분자량이 503 dalton이고 알리사이클릭 유도체로 구성된 항진균성 항생물질을 다량 생산하는 뛰어난 효과가 있으며 특히, 고추역병과 고추시드름병의 방제효과에 뛰어난 효과가 있다.The present invention relates to a novel antagonistic actinomycete strain Promicromonospora sp.KH-28 (Accession No. KCTC8946P) and to a method for producing antifungal antibiotics using the same, which comprises chitinase and antibiotics. Simultaneous production of phytopathogenic fungi Fusarium solani , Fusarium oxysporum , Alternaria mali , Phytophthora capsici , and Altera Kiki Alternaria kiki ) strongly inhibits the KH-28 from Promicromonospora genus, which is strongly inhibited, and is isolated from cultivated soils. The strain has a molecular weight of 503 daltons when incubated at pH 7.0 at 30 ° C for 5 days. It has an excellent effect of producing a large amount of antifungal antibiotics composed of alicyclic derivatives, and is particularly effective in controlling pepper blight and pepper seedling disease. And it is.
Description
본 발명은 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)(기탁번호 KCTC8949P) 및 이를 이용한 항진균성 항생물질의 생산방법에 관한 것이다. 더욱 상세하게, 본 발명은 키틴나아제와 항진균성 항생물질을 동시에 생산하는 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28과 이 균주가 생산하는 항진균성 항생물질의 생산방법에 관한 것이다.The present invention relates to a novel antagonistic actinomycete strain Promicromonospora sp. KH-28 (Accession No. KCTC8949P) and a method for producing antifungal antibiotics using the same. More specifically, the present invention relates to a novel antagonistic actinomycetes promicromonosporus KH-28 which simultaneously produces chitinase and antifungal antibiotics and a method for producing antifungal antibiotics produced by the strain. .
오늘날 산업발전으로 인류생활이 윤택해 짐에 따라 환경오염문제가 심각해지고 있다. 특히 농업의 발전은 화학비료 및 화학농약의 사용을 증가시켜 더욱 심각한 환경문제를 야기하고 있다. 화학농약의 과다사용으로 인하여 식물병원균의 화학농약에 대한 저항성 획득, 잔류독성, 토양의 산성화, 인축의 독성, 천적에 미치는 영향과 식수원의 오염 및 생태계 파괴 등 그 피해가 날로 심각해지고 있다. 따라서 이와 같은 화학농약에 의한 극심한 부작용으로부터 벗어나기 위한 대체방법의 하나로 토양내의 길항 미생물에 의한 식물병원균의 억제방법인 생물방제법이 연구되고 있다(Siegal. M. and Sisler, H.D. 1977.).Today, as the development of human life is enhanced by industrial development, the problem of environmental pollution is getting serious. In particular, the development of agriculture increases the use of chemical fertilizers and chemical pesticides, causing more serious environmental problems. Due to the overuse of chemical pesticides, the damage of phytopathogens against chemical pesticides, residual toxicity, acidification of soil, poisoning of livestock, impact on natural enemies, pollution of drinking water sources and destruction of ecosystems are becoming more serious. Therefore, as one of the alternative methods to escape from the severe side effects caused by such chemical pesticides, a biocontrol method, which is a method of inhibiting phytopathogens by antagonistic microorganisms in soil, has been studied (Siegal. M. and Sisler, H.D. 1977.).
미생물을 이용한 생물방제법으로는 진균성 식물병원균의 세포벽 구성성분인 키틴(chitin), β-1,3-글루칸(β-1,3-glucan), 만난(mannan) 등의 물질을 분해할 수 있는 키틴나아제(chitinase), 글루카나아제(glucanase), 만나아제(mannase) 등의 가수분해효소를 이용하는 방법(Julieta U. Correa, Elango, N., Polacheck, L., and Cabib, E. 1982., Sivan, A. and I. Chet. 1989., Skujus, J.J., H.J. Potgieter and M. Alexander. 1965.)과 길항미생물의 특이적 2차 대사산물인 항생물질을 분비하여 식물성 병원균의 생육을 직접 억제하는 항생기작이 있다(Brown, J.G. and A.M. Boyle. 1944.). 이러한 항생물질들은 대부분 스트렙토마이세스(Streptomyces) 속에 의하여 생산되며 의학용 항생제 개발로 많이 활용되고 있으나 농업용 미생물 농약제제로서의 산업화도 많은 가능성을 가지고 있다. 또한 토양환경 내에서 식물병원균의 생육에 필요한 금속염( Fe2+)을 경쟁적으로 흡수결합(chelating)하는 사이드로포어(siderophore)라는 물질을 생산함으로서 병원성 진균의 생육을 저해하는 기작을 이용하는 생물방제법도 연구하고 있다(Neilands, J.B. 1984., Teintze, M., M.B. Hossain, C.L. Barnes, J. Leong,and D.V. Helm. 1981.). 그러나 지금까지 미생물을 이용한 생물학적 방제방법으로서 외막가수분해효소나 항생물질을 단일로 생산하는 길항균주는 큰 효과를 거두지 못한 것이 사실이다. 외막가수분해 효소인 키틴나아제와 항진균성 항생물질을 동시에 생산하는 다기능 길항균주를 선발한다면 매우 효과적인 생물방제법이 가능할 것이다.Biocontrol methods using microorganisms can decompose substances such as chitin, β-1,3-glucan, and mannan, which are the cell wall components of fungal phytopathogens. Method of using hydrolase such as chitinase, glucanase, mannase, etc. (Julieta U. Correa, Elango, N., Polacheck, L., and Cabib, E. 1982. , Sivan, A. and I. Chet. 1989., Skujus, JJ, HJ Potgieter and M. Alexander. 1965.) and direct inhibition of the growth of plant pathogens by secreting antibiotics, specific secondary metabolites of antagonists. There is an antibiotic mechanism (Brown, JG and AM Boyle. 1944.). Most of these antibiotics are streptomyces (Streptomyces) It is produced by the genus and is widely used for the development of medical antibiotics, but industrialization as agricultural microbial pesticides has many possibilities. In addition, metal salts necessary for the growth of phytopathogens in soil environment (Fe2+We are also studying biocontrol using a mechanism that inhibits the growth of pathogenic fungi by producing a material called siderophore that competitively chelates (Neilands, JB 1984., Teintze, M., MB). Hossain, CL Barnes, J. Leong, and DV Helm. 1981.). However, until now, it is true that antagonistic strains producing single membrane hydrolase or antibiotic as a biological control method using microorganisms have not had a great effect. Selecting a multifunctional antagonist that produces both chitinase and antifungal antibiotics at the same time would be a very effective biocontrol method.
본 발명자들은 토양의 병원성진균을 특이적으로 강력하게 저해하는 길항미생물을 저병해 경작지 토양으로부터 분리하여 푸사리움 옥시스포룸(Fusarium oxysporum) 등에 의한 토양전염성 식물병원균을 방제하고자 외막가수분해효소인 키틴나아제(chitinase)와 항진균성 항생물질을 동시에 생산하므로써 두가지 길항능력을 가진 복수 기능성 토양길항방선균 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)을 선발하여 동정하였으며 선발한 길항균주가 항생물질을 생산하기 위한 최적조건을 조사하였고 생산한 항생물질을 분리, 정제하여 항생물질의 구조를 추정한 후 실제 토양내에서의 저해효과를in vivo실험으로 확인하므로써 본 발명을 완성하였다.The present inventors have isolated antagonistic microorganisms that specifically inhibit pathogenic fungi of soil, from low diseased arable soil to control soil infectious plant pathogens by Fusarium oxysporum , etc. By simultaneously producing chitinase and antifungal antibiotics, KH-28 ( Promicromonospora sp. KH-28), a multifunctional soil antagonist that has two antagonists, was identified and selected by antagonistic strains. The present invention was completed by investigating the optimum conditions for producing the substances, and after estimating the structure of the antibiotics by separating and purifying the produced antibiotics, and confirming the inhibitory effect in real soil by in vivo experiments.
본 발명의 목적은 키틴나아제와 항진균성 항생물질을 동시에 생산하는 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)를 제공함에 있다. 본 발명의 다른 목적은 상기 신규한 길항성 방선균주의 배양액으로부터 항생물질의 생산방법을 제공함에 있다.An object of the present invention is to provide a novel antagonistic actinomycetes Promicromonospora genus KH-28 ( Promicromonospora sp. KH-28) which simultaneously produces chitinase and antifungal antibiotics. Another object of the present invention to provide an antibiotic production method from the culture medium of the novel antagonistic actinomycetes.
본 발명의 상기 목적은 전국의 저병해 경작지의 토양으로부터 식물병원성 진균 푸사리움 옥시스포룸(Fusarium oxysporum)에 대한 생육억제력이 강한 키틴나아제와 항진균성 항생물질을 동시에 생산하는 길항성 방선균주를 선발하여 분류학적으로 동정하고 배양 및 생리학적으로 분석하여 신규한 길항성 방선균주임을 확인하고 이를 프로마이크로모노스포라 속 KH-28(기탁번호 KCTC 8946P)로 명명한 후 상기 균주의 식물병원균 12 균주에 대한 항균력을 조사하였으며 이어서 본 발명의 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 항생물질 생산을 위한 최적조건을 조사하고 생산된 항생물질을 추출, 정제한 후 기기분석을 통해 분석한 다음 실제로 본 발명 신규한 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 생물방제력을 식물실험을 통해 확인하므로써 달성하였다.The object of the present invention is to select antagonistic actinomycetes that simultaneously produce chitinase and antifungal antibiotics that have strong growth inhibitory activity against phytopathogenic fungi Fusarium oxysporum from soils of low disease farmland nationwide. Taxonomically identified, cultured and physiologically analyzed to identify a novel antagonistic actinomycetes and named it as KH-28 (accession number KCTC 8946P) of the genus Promicromonospora, and then to 12 strains of phytopathogens of the strain. The antimicrobial activity of KH-28 in the antagonistic actinomycetes promicromonospora of the present invention was investigated. Then, in fact, the plant's biological control ability of the novel antagonistic actinomycetes promicromonospora genus KH-28 It was achieved by OK.
이하, 본 발명의 구성 및 작용을 설명한다.Hereinafter, the configuration and operation of the present invention.
도 1은 저병해 경작지 토양내 근권으로부터 키틴나아제를 생산하는 항진균성 길항균주를 선발하기 위해 여러 균주의 키틴나아제 생산성을 나타낸 그래프이다.1 is a graph showing chitinase productivity of several strains to select antifungal antagonist strains that produce chitinase from root zones in low diseased farmland soil.
도 2는 14일 동안 ISP4 배지상에 배양한 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 포자형태를 관찰한 전자현미경 사진도이다.Figure 2 is an electron micrograph showing the spores of the genus antagonistic actinomycetes promicromonospora KH-28 incubated on ISP4 medium for 14 days.
도 3은 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 세포벽내 아미노산과 세포벽을 구성하는 디아미노피멜산(diaminopimelic acid;DAP) 이성체를 조사하기 위한 셀룰로오스 얇은 막 크로마토그라피 결과를 나타낸다.Figure 3 shows the results of cellulose thin-film chromatography to investigate the amino acid in the cell wall and diaminopimelic acid (DAP) isomer constituting the cell wall of the present invention antagonistic actinomycetes promicromonospora genus KH-28 .
도 4는 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 전체 세포 추출물에 대한 당을 셀룰로오스 얇은 막 크로마토그라피한 결과를 나타낸다.Figure 4 shows the results of the cellulose thin membrane chromatography of the sugars for the whole cell extract of the genus antagonistic actinomycetes promicromonospora genus KH-28.
도 5는 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28이 항생물질을 생산함에 있어 pH의 영향을 나타낸 그래프이다.5 is a graph showing the effect of pH in the production of antibiotics of the genus KH-28 antagonistic actinomycetes promicromonospora.
도 6은 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28이 항생물질을 생산함에 있어 온도의 영향을 나타낸 그래프이다.Figure 6 is a graph showing the effect of temperature on the production of antibiotics of the genus antagonistic actinomycetes promicromonospora KH-28.
도 7은 본 발명 길항성 방선균주 마이크로모노스포라 속 KH-28이 항생물질을 생산함에 있어 배양시간의 영향을 나타낸 그래프이다.Figure 7 is a graph showing the effect of incubation time in the production of antibiotics KH-28 genus antagonistic actinomycetes micromonospora of the present invention.
도 8은 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28이 생산하는 항생물질의1H-NMR 스펙트럼을 나타낸다.Figure 8 shows the 1 H-NMR spectrum of the antibiotic produced by the antagonistic actinomycetes strain Promicromonospora KH-28 of the present invention.
도 9는 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28이 생산하는 항생물질의 Fab-mass 스펙트럼을 나타낸다.9 shows Fab-mass spectra of antibiotics produced by the present invention antagonistic actinomycetes promicromonospora genus KH-28.
본 발명은 전국각지의 저병해 경작지 토양으로부터 길항성 방선균주을 선발하는 단계; 상기 선발한 길항성 방선균주를 키틴나아제 생산배지에서 배양하면서 항진균성 키틴나아제 생산성을 조사하고 키틴나아제 효소의 활성도를 측정한 후 상기 키틴나아제를 생산하는 길항성 방선균주 중에서 항진균성 항생물질을 생산하는 균주만을 선발하는 단계; 상기 선발한 키틴나아제와 항생물질을 생산하는 균주를버지의 미생물 분류법과 일반 세균학법에 기준하여 동정한 결과에 의해 본 발명 길항성 방선균주를 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)(기탁번호 KCTC 8946P)로 명명하는 단계; 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 항균력 범위를 12종류의 식물병원성 진균류를 대상으로 조사하는 단계; 변형시킨 베넷(Bennett)배지를 기본배지로 사용하여 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 항생물질 생산을 위한 최적의 배양온도, pH 및 배양시간을 조사하는 단계; 본 발명의 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 배양여액을n-부탄올로 추출한 후 실리카겔 컬럼크로마토그라피와 세파덱스 컬럼 크로마토그라피로 정제하여 항생물질을 추출 및 정제하는 단계; 상기 추출 및 정제한 항생물질을 자외선 분광기, TLC, 질량분석기, 핵자기 공명 분광기 등의 분석기기를 이용하여 분석하는 단계 및; 푸사리움 옥시스포룸 병원균에 감염된 고추를 발병기주식물로 토양에 심고 상기 토양에 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28을 주입한 후 식물생장의 생육도를 조사하는 단계로 구성된다.The present invention comprises the steps of selecting the antagonistic actinomycetes from low diseased arable lands of the country; After culturing the selected antagonistic actinomycetes in a chitinase production medium, the antifungal chitinase production was investigated, the activity of chitinase enzymes was measured, and the antifungal antibiotics were produced in the antagonistic actinomycetes producing chitinase. Selecting only strains producing the substance; The antagonistic actinomycetes of the present invention were identified as the result of the identification of the above-described chitinase and antibiotic-producing strains based on the microbial classification method and the general bacteriology method of the genus KH-28 ( Promicromonospora sp. KH-28) (Accession No. KCTC 8946P); Investigating the antimicrobial activity of the antagonistic actinomycetes promicro monospora genus KH-28 in 12 kinds of phytopathogenic fungi; Investigating the optimal culture temperature, pH and incubation time for the production of antibiotics of the antagonistic actinomycetes promicromonospora genus KH-28 using the modified Bennett medium as a base medium; Extracting and purifying antibiotics by extracting the culture filtrate of KH-28 of the genus antagonistic actinomycetes promicromonospora of the present invention with n -butanol and then purifying with silica gel column chromatography and Sephadex column chromatography; Analyzing the extracted and purified antibiotics using an analyzer such as an ultraviolet spectrometer, a TLC, a mass spectrometer, and a nuclear magnetic resonance spectrometer; Planting peppers infected with Fusarium oxysporum pathogen into the soil as a disease-bearing plant and injecting the antagonistic actinomycetes promicromonosporus genus KH-28 of the present invention into the soil and then investigating the growth of plant growth do.
이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.
실시예 1: 길항성 방선균주 분리Example 1 Isolation of Antagonistic Actinomycetes
전국 각지의 저병해 경작지 토양을 대상으로 방선균을 선발하기 위해 근권(rhizosphere) 토양시료 1g 씩을 채취하여 80℃에서 30분 정도 열처리한 후 멸균 생리식염수 10mL에 넣고 20분 동안 교반한 다음 멸균수로 10-3~ 10-5배로 희석하여 0.1mL를 분리용 배지 전분-질산염 아가(starch-nitrate agar) 배지에 도말한 후 28℃에서 2 ~ 4 주간 배양하여 나타난 사상 형태의 집락(colony)을 분리하였다. 실험결과, 상기 배양하여 분리한 균주의 집락형태 및 광학현미경상에서 관찰한 전형적인 방선균형태의 500여 균주를 1차로 선발하였으며 이를 동결 건조하여 보관하였다.To select actinomycetes from low-border arable soils around the country, 1 g of rhizosphere soil samples were collected, heat-treated at 80 ° C for 30 minutes, and then placed in 10 mL of sterile saline solution and stirred for 20 minutes. Diluted at -3 to 10 -5 times, 0.1mL was separated into starch-nitrate agar medium for separation, followed by incubation at 28 ° C for 2 to 4 weeks to isolate the filamentous colony. . As a result, over 500 strains of the typical actinomycetes observed in colony and optical microscopy of the cultured and isolated strains were firstly selected and stored by lyophilization.
실시예 2: 길항성 방선균주의 항진균성 키틴나아제 생산성 및 활성도Example 2: Antifungal Chitinase Productivity and Activity of Antagonistic Actinomycetes
실시예 1에서 선발한 길항성 방선균주를 대상으로 키틴나아제(chitinase)를 생산하는지의 여부를 조사하기 위하여 키틴나아제(chitinase) 생산배지 (colloidal chitin 4g, K2HPO40.7g, MgSO4·5H2O 0.5g, KH2PO40.3g, FeSO4.·7H2O 0.01g, MnCl21.0 mg, ZnSO41,0 mg, agar 20g, pH 7.0)의 플레이트(plate) 상에 분리한 균주를 접종 한 후 콜로이드성 키틴(colloidal chitin)이 분해되어 클리어 존(clear zone)을 형성하는지의 유무를 조사하였다. 또한 한천을 첨가하지 않은 키틴나아제 생산배지에 4 일간 배양시켜 원심분리한 후 배양상등액을 황산암모늄으로 침전시키고 맴브레인 색(membrane sack;M.W 12,000)으로 투석하여 조정제된 키틴나아제 효소를 얻었다. 효소활성측정은 0.1M 시트레이트 버퍼(citrate buffer;pH 6.0) 2.0mL 과 0.5 % 의 콜로이드성 키틴 1.0 mL을 넣고 효소액의 2.0mL을 넣어 40℃에서 1시간 동안 진탕반응시킨 후 1mL의 반응여액을 100℃에서 15분간 가열하여 반응을 정지시켰다. 그 반응액을 분해가 되지 않은 키틴과 분리하기 위해 5000rpm으로 원심분리시킨 후 상등액 내의 N-아세틸글루코사민(N-acetylglucosamine)의 양을 Reissig 등에 의한 방법에 따라 확인하였으며, 키틴나아제 활성의 1 Unit 는 1μM의 N-아세틸글루코사민(N-acetylglucosamine)을 생성하는 효소의 양으로 정의하였다. 상기 선발한 키틴나아제를 생산하는 방선균 중에서 항진균성 항생물질을 생산하는 균주를 선발하기 위해 베넷(Bennett)배지 (glucose 10g, peptone 2g, yeast extract 1g, beef extract 1g, pH 7.0) 에서 28℃, 5일간 배양시킨 배양 여액을 맴브레인 색(membrane sack ;Sigma, Co., M.W 12,000)으로 여과하여 저분자와 고분자물질을 분리한 후 식물 근부균인 푸사리움 옥시스포룸(Fusarium oxysporum)을 대상으로 페이퍼 디스크(paper disk) 법에 의해 항균력을 조사하였다. 실험결과, 도 1에서 보는 바와 같이 항진균성 활성이 가장 강하고 세포외막 가수분해 효소인 키틴나아제(chitinase) 생산성이 강한 KH-28 균주를 선발하였다.In order to investigate whether chitinase is produced in the antagonistic actinomycetes selected in Example 1, chitinase production medium (colloidal chitin 4g, K 2 HPO 4 0.7g, MgSO 4 · 5H 2 O 0.5g, KH 2 PO 4 0.3g, FeSO 4. · 7H 2 O 0.01g, MnCl 2 1.0 mg, plate (separate to the plate) of ZnSO 4 1,0 mg, agar 20g, pH 7.0) After inoculation of one strain, it was examined whether colloidal chitin was decomposed to form a clear zone. In addition, the culture supernatant was precipitated with ammonium sulfate and dialyzed with membrane color (membrane sack; MW 12,000) to obtain a modified chitinase enzyme. Enzyme activity was measured by adding 2.0 mL of 0.1M citrate buffer (pH 6.0) and 1.0 mL of 0.5% colloidal chitin, adding 2.0 mL of enzyme solution and shaking for 1 hour at 40 ° C. The reaction was stopped by heating at 100 ° C. for 15 minutes. The reaction solution was centrifuged at 5000 rpm to separate it from undecomposed chitin, and the amount of N-acetylglucosamine in the supernatant was confirmed by the method of Reissig et al. It was defined as the amount of enzyme that produced 1 μM of N-acetylglucosamine. 28 ° C in Bennett medium (glucose 10g, peptone 2g, yeast extract 1g, beef extract 1g, pH 7.0) to select strains that produce antifungal antibiotics among the selected actinomycetes producing chitinase The culture filtrate incubated for 5 days was filtered through membrane color (membrane sack; Sigma, Co., MW 12,000) to separate small molecules and polymers, and then to the Fusarium oxysporum , a plant root bacterium. The antimicrobial activity was investigated by paper disk method. As a result, as shown in FIG. 1, the KH-28 strain having the strongest antifungal activity and the extracellular chitinase productivity was selected.
실시예 3: 본 발명 길항방선균의 분류학적 동정Example 3: Taxonomic Identification of the Antagonists of the Invention
실시예 2에서 선발한 길항성 방선균주 KH-28을 버지의 미생물분류법(Bergey's manual of systematic bacteriology) 과 일반세균학법( Manual of methods for general bacteriology)에 준하여 분류학적으로 동정하였으며, 특히 방선균의 경우 국제 스트렙토마이세스 프로젝트(International Streptomyces Project;ISP), 뉴메리칼 탁소노미(numerical taxonomy) 방법에 의해 동정하였다. 형태학적 특성은 국제 스트렙토마이세스 생산(InternationalStreptomyces Product;ISP) 배지에서 배양한 후 광학현미경 및 전자현미경으로 관찰하였으며, 생화학적 특성은 세포벽 내의 디아미노피멜산(diaminopimelic acid) 분석, 세포 내의 당 분석 등으로 확인하였다. 또한 생리학적 특성은 탄소원과 질소원의 이용성, 항균활성시험, 기질분해 여부 등을 조사하였다. 이와 같은 41가지 단위형질 실험결과를 Ward 등에 의해 개발된 컴퓨터 프로그램인 TAXON 프로그램을 이용하여 스트렙토마이세스 속(Streptomycessp) 및 종(species)단계로 확률적인 수리 동정을 하였다. 실험결과, 표 1에 나타낸 바와 같이 12 가지 배지에서 대체로 생육이 좋았으나 ISP6과 ISP7 배지에서는 생육이 좋지 못하였다. 기균사는 회색이었으며, 배지 내의 색소는 대체로 갈색을 형성하였고, ISP1 과 ISP5 배지에서는 황색을 나타내었다. 형태적 특징은 ISP4 배지에서 생장한 집락을 이용하여 전자현미경(SEM)상에서 포자의 형태를 관찰한 결과 도 2 에 나타낸 바와 같이 포자 형태는 주름형(rugose)이고, 포자의 사슬은 나선형(spirales)으로 나타났다(표 2). 방선균 내의 세포벽 성분인 LL, 메조(meso) 및 3-OH 디아미노피멜산(3-OH diaminopimelic acid;DAP)의 구성을 확인한 결과 도 3 에 나타낸 바와 같이 디아미노피멜산(diaminopimelic acid)으로 구성되어있지 않음을 확인할 수 있었다. 또한 세포내의 총당 분석은 도 4에 나타난 것과 같이 어떠한 당도 확인할 수 없었다. 따라서 본 발명 길항 방선균주 KH-28은 스트렙토마이세스(Streptomyces)속의 특징인 LL-DAP를 함유하고 있는 것과 다른 결과를 나타냈으며, 버지의 미생물분류법 볼륨 4(Bergey's manual 의 volumn 4)에서 확인 한 결과 프로마이크로모노스포라(Promicromonospora)속에 속하는 것이 가장 적합한 것으로 나타났다. 또한 본균주의 배양, 생리적 특징 등을 확인한 결과 최적 성장온도는 30℃이며, 45℃에서도 생육이 가능하였으며 또한 pH 10에서도 생육이 가능하였으나, 10℃와 pH 4.3 에서는 생육하지 않았다 (표 3). 레시티나아제(Lecitinase), 리포라이틱 효소(lipolytic enzyme) 등의 단백질분해효소는 생산하지 않았으나, 키틴(chitin) 및 펙틴(pectin)의 분해력은 강하게 나타났다. 항생제인 네오마이신(neomycin), 리팜피신(rifampicin)과 NaCl, 소듐 아지드(sodium azide), 페놀(phenol) 등의 저해제에서는 저항성이 없었다. 하이드로전 설파이드(Hydrogen sulfide) 생산 및 크산틴(xanthine) 분해에서는 양성을 나타내었으나, 질산염(nitrate) 생산 및 알란토인(allantoin), 알부틴(arbutin) 분해에서는 음성을 나타내었다. 바실러스 서브틸리스(Bacillus subtillis),슈도모나스 플루오레센스(Psudomonas fluoresence) 균주에 대해서는 항균력을 나타내었으나 아스퍼질러스 나이거(Aspergillus niger)에 대해서는 항균력을 나타내지 않았다. 또한 당 이용성 실험에서는 대체로 좋은 편이었으나 D-프럭토오스(D-fructose), 아도니톨(adonitol), 셀로바이오스(cellobiose)에서는 생장력이 약하게 나타났다. 질소원 이용성에서는 L-히스티딘(L-histidine)에서 생육력이 낮게 나타났다. 이와 같은 분석 결과로 프로마이크로모노스포라(Promicromonospora)속임을 확인하였다. 따라서 본 발명 길항성 방선균주를 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)로 명명하였으며 생명공학연구소내 유전자은행에 1999년 6월 14일 KCTC 8946P로 기탁하였다.The antagonistic actinomycetes KH-28 selected in Example 2 were identified taxonomically in accordance with Bergy's manual of systematic bacteriology and Manual of methods for general bacteriology, especially for actinomycetes. The Streptomyces Project (ISP), Numerical Taxonomy Method was identified. Morphological characteristics were observed by light microscopy and electron microscopy after incubation in International Streptomyces Product (ISP) medium, and biochemical properties were analyzed by diaminopimelic acid in cell wall, glucose analysis in cell, etc. It was confirmed. In addition, the physiological characteristics of carbon and nitrogen sources, antimicrobial activity test and substrate degradation were examined. The results of 41 unit trait experiments were stochastically identified by Streptomyces sp and species by using the TAXON program, a computer program developed by Ward et al. As a result, as shown in Table 1, growth was generally good in 12 medium, but poor in ISP6 and ISP7 medium. The aerial mycelium was grey, and the pigment in the medium was generally brown, and yellow in ISP1 and ISP5 medium. Morphological characteristics of the spores were observed on an electron microscope (SEM) using colonies grown in ISP4 medium. As shown in FIG. 2, the spores form a rugose and the chains of the spores are spiraled. (Table 2). As a result of confirming the composition of LL, meso and 3-OH diaminopimelic acid (DAP), which are cell wall components in actinomycetes, it is composed of diaminopimelic acid (diaminopimelic acid) as shown in FIG. It could be confirmed that it is not. In addition, the total sugar analysis in the cell could not identify any sugar as shown in FIG. Therefore, the antagonistic actinomycetes KH-28 of the present invention showed different results from those containing LL-DAP, which is a characteristic of Streptomyces genus, and was confirmed by the microorganism classification volume 4 (volumn 4 of the Bergy's manual). The genus Promicromonospora has been shown to be most suitable. In addition, the optimum growth temperature was 30 ℃, the growth was possible at 45 ℃ and also at pH 10, but did not grow at 10 ℃ and pH 4.3 as a result of confirming the culture, physiological characteristics, etc. of the main strain (Table 3). Proteases such as lecitinase and lipolytic enzymes were not produced, but the degradability of chitin and pectin was strong. Inhibitors such as antibiotics neomycin, rifampicin and NaCl, sodium azide and phenol were not resistant. Hydrogen sulfide production and xanthine degradation were positive, but nitrate production and allantoin and arbutin degradation were negative. Antibacterial activity was shown against Bacillus subtillis and Psudomonas fluoresence strains, but not against Aspergillus niger . In addition, sugar utilization was generally good, but D-fructose, adonitol, and cellobiose showed weak growth. Nitrogen availability was low in L-histidine. As a result of the analysis it was confirmed that the genus Promicromonospora ( Promicromonospora ). Therefore, the antagonistic actinomycetes of the present invention was named Promicromonospora sp.KH -28 ( Promicromonospora sp. KH-28) and was deposited as KCTC 8946P on June 14, 1999 at the Gene Bank in the Biotechnology Research Institute.
실시예 4: 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 여러 식물병원균 생장 억제Example 4: Inhibition of growth of various phytopathogens of the present invention antagonistic actinomycetes promicromonospora genus KH-28
길항성 방선균주 프로마이크로모노스포라 속 KH-28(Promicromonosporasp. KH-28)을 배양시킨 배양여액을n-부탄올층에 추출하여 농축한 물질을 페이퍼 디스크(paper disk)법에 의해 식물병원균 생장 저해력을 조사하였다. 실험결과, 표 4 에서와 같이 푸사리움 솔라니(F. solani),푸사리움 옥시스포름(F. oxysporum),얼터나리아 마리(Alternaria mali),파이토프토라 캡시씨(Phytophthora capsici),얼터나리아 키키(Alternaria kiki) 등의 진균에 억제력을 나타내었으며, 콜레토트리쿰 글로에오스포리오이데스(Colletotrichum gloeosporioides),페니실리움 엑스판슘(Penicillum expansum),푸사리움 모니(F. moni),라이조크토니아 속(Rizoctoniasp.) 등의 병원성진균에는 저해력을 나타내지 않았다.Antagonistic actinomycetes Promicro monospora genus KH-28 (Promicromonosporasp. KH-28) cultured filtraten-The inhibitory activity of phytopathogen growth was examined by the paper disk method of the material extracted and concentrated in the butanol layer. Experimental results, as shown in Table 4 Fusarium Solani (F. solani),Fusarium oxysporm (F. oxysporum),Alternaria MarieAlternaria mali),Phytophthora Capsi (Phytophthora capsici),Alterna Kiki (Alternaria kiki) It showed inhibitory effect on the fungus, etc., and choletotricum gloeosporioides (Colletotrichum gloeosporioides),Penicillium Expanium(Penicillum expansum),Fusarium Moni(F. moni),Raizoktonia(Rizoctoniasp.) and other pathogenic fungi did not show inhibition.
실시예 5: 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 항생물질 생산을 의한 최적 조건Example 5 Optimal Conditions by Antibiotic Production of the Agonist Actinomycetes Promicromonospora Species KH-28
실시예 2에서 선발한 항진균성 길항성 방선균주의 항생물질 생산에 미치는 최적의 배양시간을 조사하기 위하여 각각의 항생물질 생산배지에 종균 배양시킨 선발균을 1% 되게 접종하여 30℃에서 배양하면서 시간별로 균의 성장 및 배양 상등액에서의 푸사리움 옥시스포룸(F. oxysporum)에 대한 길항능을 각각의 분석 방법에 의해 조사하였다. 또 선발한 항진균성 길항성 방선균주의 항생물질 생산에 미치는 최적의 배양온도 및 pH의 영향을 조사하기 위하여 항생물질 생산배지(글루코스 10g, 펩톤 2g, 효모 추출물 1g, 육수 1g, pH 7.0)에 균주를 접종하고 각 배양온도별로 배양하면서 항진균성 항생물질의 생산을 분석하였다. 또한 항생물질 생산배지의 초기 pH를 2 ~ 11 까지 조절하여 항생물질 생산율을 분석하였다. 이때, 기본배지는 베넷배지를 이용하였으며 배양여액을n-부탄올로 추출하여 100배 농축시킨 후 페이퍼 디스크(paper disk) 법으로 저해 지대(inhibition zone)의 거리를 3 회 반복 확인하여 평균 저해거리를 조사하였다. 실험결과, pH 에 따른 항생물질 생산은 도 5 에서 나타난 것과 같이 pH 7.0 에서 가장 생산력이 높았으며 pH 5 ~ 9범위내에서는 비교적 양호한 편이였다. 또한 길항성 방선균주 프로마이크모노스포라 속 KH-28의 생육온도에 의한 항생물질 생산에 미치는 영향을 조사하기 위하여 15℃에서 45℃까지 항생물질 생산능을 조사 한 결과 도 6에 나타낸 바와 같이 30℃에서 배양시켰을 경우 생산력이 가장 높게 나타났으며 26 ~ 40℃ 범위내에서는 비교적 양호한 편이였다. 배양시간에 의한 항생물질 생산성을 확인하기 위하여 접종 후 배양시간 별로 7 일간 배양시킨 결과 도 7 에 나타낸 바와 같이 5 일 배양시켰을 경우 생산력이 가장 높게 나타났으며 5 일 이후 저해력의 변화가 없다가 7일 이후 저해력이 약간씩 떨어짐을 알 수 있었다.In order to investigate the optimal incubation time for the antibiotic production of the antifungal antagonistic actinomycetes selected in Example 2, inoculated with 1% of the starter cultures spawned in each antibiotic production medium to incubate at 30 ° C. The growth and bacterial antagonism of F. oxysporum in the culture supernatants was investigated by the respective analytical methods. In order to investigate the effects of optimal culture temperature and pH on the production of antibiotics of selected antifungal antagonistic actinomycetes, strains were added to antibiotic production medium (glucose 10g, peptone 2g, yeast extract 1g, broth 1g, pH 7.0). Inoculation and incubation at each culture temperature were analyzed for the production of antifungal antibiotics. In addition, the antibiotic production rate was analyzed by adjusting the initial pH of the antibiotic production medium to 2-11. At this time, the basic medium was Bennett medium, and the culture filtrate was extracted with n -butanol, concentrated 100 times, and the average inhibition distance was determined by checking the distance of the inhibition zone 3 times by the paper disk method. Investigate. As a result, antibiotic production according to pH was the most productive at pH 7.0 as shown in Figure 5 and relatively good within the pH range of 5-9. In addition, in order to investigate the effect on the production of antibiotics by the growth temperature of the antagonistic actinomycetes promic monospora KH-28, the production of antibiotics from 15 ℃ to 45 ℃ as shown in Figure 6 30 When incubated at ℃ was the highest productivity and was relatively good within the range of 26 ~ 40 ℃. In order to confirm the antibiotic productivity by incubation time, after 7 days of incubation for each incubation time, as shown in FIG. 7, the highest productivity was obtained when incubated for 5 days and there was no change in inhibition after 5 days. After days, the inhibition was slightly decreased.
실시예 6: 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 배양액으로부터 항생물질 추출 및 정제Example 6: Extraction and Purification of Antibiotics from the Culture of KH-28 Genus Antagonistic Actinomycetes Promicromonospora
본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28이 생산하는 항생물질을 분리정제하기 위해 10L의 배지에 5일간 배양시킨 배양여액을 여과한 후 유기용매인n-부탄올로 추출하여n-부탄올층을 농축하고 증류수로 녹인 후 1일 동안 4℃에서 저장한 다음 원심분리한 침전물을 메탄올에 녹여 실리카겔 컬럼 크로마토그라피(70-230 메쉬, 머크, 4 × 20cm)에 메탄올:H2O을 7:3 비율로 전개시켰다. 또한 세파덱스 LH-20 컬럼 크로마토그라피(머크, 4 × 20cm)를 이용하여 메탄올로 용출시켰다.The present invention Antagonistic Actinomycetes main Pro micro mono spokes la in KH-28 The production of the 5-day medium 10L for separating and purifying the antibiotics that was filtered, after which the culture filtrate cultured n is an organic solvent-extracted with n- butanol The butanol layer was concentrated, dissolved in distilled water, stored at 4 ° C. for 1 day, and the centrifuged precipitate was dissolved in methanol to obtain methanol: H 2 O in silica gel column chromatography (70-230 mesh, Merck, 4 × 20 cm). It was developed at a ratio of 3: 3. It was also eluted with methanol using Sephadex LH-20 column chromatography (Merck, 4 x 20 cm).
실시예 7: 본 발명 길항성 방선균주가 생산하는 항생물질의 기기분석Example 7: Instrumental analysis of antibiotics produced by the antagonistic actinomycetes of the present invention
상기 실시예 6에서 추출 및 정제한 항생물질을 자외선 분광기(UV), 얇은 막 크로마토그라피(TLC), 질량분석기(mass spectrometry, MS), 핵자기 공명 분광기(nuclear magnetic resornance, NMR) 등의 분석기를 이용하여 분석하였다. 실험결과, 표 5에 나타낸 바와 같이 항생물질은 황색색소로 구성되고 있었고 정제된 항생물질의 특성은n-부탄올, 메탄올, 에탄올 등의 용매에 용해성을 확인할 수 있었으며 클로로포름, 톨루엔,n-헥산 등에 용해되지 않았다. 여러 가지 생화학적 반응 검사에서 2:4-디니트로하이드라진(2:4-Dinitrohydrazine)에 양성반응을 나타내며 UV 조사결과 형광색을 나타냈다. 그러나 닌히드린 반응 등 아미노산 구성물질 확인 반응에서는 음성으로 나타났으며 DNS법에 의한 비환원성 당 실험결과에서도 음성으로 나타났다. 전개용매를 에탄올:암모니아:물=8:1:1로 하여 실리카겔 TLC 상에서 전개하여Rf치를 확인한 결과 0.87로 나타났다. 그리고 UV 흡광 스펙트럼은 260과 440nm에서 흡광을 나타냈다. 도 8, 도 9에 나타낸1H-NMR과 Fab mass 스펙트럼을 보면 7.713, 7.627, 4.275ppm의 피크에서 피리미딘 골격을 가진 구조를 구성함을 알수 있고 2.149, 1.884, 1.345, 0.972, 0.867 ppm의 피크에서 긴 알리파틱 체인의 수소기를 확인할 수 있었다. 또한 분자량이 503 dalton으로 나타났다.The antibiotics extracted and purified in Example 6 were analyzed using an ultraviolet spectrometer (UV), thin film chromatography (TLC), mass spectrometry (MS), nuclear magnetic resonance spectroscopy (NMR), etc. The analysis was carried out. As a result, as shown in Table 5, the antibiotics were composed of yellow pigment, and the characteristics of the purified antibiotics were found to be soluble in solvents such as n -butanol, methanol, and ethanol, and dissolved in chloroform, toluene, n -hexane, etc. It wasn't. Various biochemical reactions showed positive reactions to 2: 4-dinitrohydrazine (2: 4-Dinitrohydrazine) and showed fluorescent color upon UV irradiation. However, it was negative in the amino acid component identification reaction such as ninhydrin reaction and negative in the non-reducing sugar test results by DNS method. The developing solvent was developed on silica gel TLC with ethanol: ammonia: water = 8: 1: 1 to confirm Rf value of 0.87. UV absorbance spectra showed absorbance at 260 and 440 nm. The 1 H-NMR and Fab mass spectra shown in FIGS. 8 and 9 show that the pyramidine skeleton has a structure at peaks of 7.713, 7.627, and 4.275 ppm, and peaks of 2.149, 1.884, 1.345, 0.972, and 0.867 ppm. The hydrogen group of the long aliphatic chain was found in. It also showed a molecular weight of 503 dalton.
실시예 8: 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28의 식물실험을 통한 생물방제력 조사Example 8 Investigation of Biocontrol Activity by Plant Experiment of Inventive Antagonistic Actinomycetes Promicromonospora Genus KH-28
본 실시예에서는 본 발명 길항성 방선균주인 프로마이크로모노스포라 속 KH-28의 식물병원균에 저해력을 가지는지 확인하기 위해 고추를 발병기주식물로 하여 28℃ 항온실에서 페트리 디시(petri dish) 상에 여과지를 2장정도 깐 다음 적당히 물을 적신 후 고추종자를 3일간 배양시킨 후 발아가 되는 종자만을 선별하였다. 멸균시킨 베르무컬리트(bermuculite)가 들어있는 24구 플라스틱 화분에 이식하여 3배엽으로 자랐을 때 다른 멸균한 베르무컬리트와 병원균 및 길항성 방선균주를 혼합한 24구 플라스틱 화분에 이식하여 식물의 생육을 관찰하였다. 실험결과 병원균만 접종한 A구에 비해 병원균과 길항균을 혼합한 B구와 길항균과 병원균을 접종하지 않은 C구인 대조구의 생육이 좋음을 확인할 수 있었고 특히 대조구 C구에 비해 병원균과 길항균이 혼합된 B구가 기주식물의 생육이 양호함을 알 수 있었다.In the present embodiment, to determine whether the antagonistic actinomycetes strain of the present invention, Promicromonospora genus KH-28 inhibits phytopathogens, the pepper as a pathogen plant in a petri dish at 28 ℃ constant temperature room After two sheets of filter paper, the water was soaked properly and incubated for 3 days, the seeds were selected to germinate. When transplanted into a 24-neck plastic pot containing sterilized bermuculite and grown into three germ layers, it was transplanted into a 24-neck plastic pot mixed with other sterilized vermuculites, pathogens and antagonistic actinomycetes. Growth was observed. Experimental results showed that B group mixed with pathogens and antagonists was better than A group inoculated with pathogens and control group C, which was not inoculated with antagonists and pathogens, and especially B group mixed with pathogens and antagonists than control group C. The growth of host plants was found to be good.
이상, 상기 실시예를 통하여 설명한 바와 같이, 저병해 경작지의 토양으로부터 선발하여 프로마이크로모노스포라 속으로 동정한 본 발명 길항성 방선균주 프로마이크로모노스포라 속 KH-28(기탁번호 KCTC8946P)은 식물병원성 진균인 푸사리움 솔라니, 푸사리움 옥시스포룸, 얼터나리아 마리, 파이토프토라 캡시씨, 얼터나리아 키키를 강력하게 저해하는 뛰어난 효과가 있다. 또 본 발명의 길항성 방선균주는 pH 7.0, 온도 30℃에서 5일간 배양했을 경우 분자량이 503dalton이고 알리사이클릭유도체로 구성된 항생물질을 다량 생산하는 뛰어난 효과가 있으므로 생물농약 산업상 매우 유용한 발명인 것이다.As described above, the antagonistic actinomycete strain Promicromonosporus genus KH-28 (Accession No. KCTC8946P) of the present invention selected from the soil of low disease farmland and identified as promicromonospora is a plant. It has an excellent effect of strongly inhibiting the pathogenic fungi Fusarium solanie, Fusarium oxysporum, Alternaria Marie, Phytopopera capsi and Alternaria Kiki. In addition, the antagonistic actinomycete of the present invention is a very useful invention for the biopesticide industry because it has an excellent effect of producing a large amount of antibiotics composed of alicyclic derivatives having a molecular weight of 503dalton when incubated at pH 7.0 and a temperature of 30 ° C for 5 days.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990027196A KR100333039B1 (en) | 1999-07-07 | 1999-07-07 | Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990027196A KR100333039B1 (en) | 1999-07-07 | 1999-07-07 | Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010009048A KR20010009048A (en) | 2001-02-05 |
KR100333039B1 true KR100333039B1 (en) | 2002-05-27 |
Family
ID=19599841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990027196A KR100333039B1 (en) | 1999-07-07 | 1999-07-07 | Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100333039B1 (en) |
-
1999
- 1999-07-07 KR KR1019990027196A patent/KR100333039B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010009048A (en) | 2001-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kathiresan et al. | Fungicidal activity of marine actinomycetes against phytopathogenic fungi | |
Ilic et al. | Characterization and antimicrobial activity of the bioactive metabolites in streptomycete isolates | |
Trejo-Estrada et al. | In vitro and in vivo antagonism of Streptomyces violaceusniger YCED9 against fungal pathogens of turfgrass | |
Thakur et al. | Isolation and screening of Streptomyces in soil of protected forest areas from the states of Assam and Tripura, India, for antimicrobial metabolites | |
Harikrishnan et al. | Antagonistic potential of native strain Streptomyces aurantiogriseus VSMGT1014 against sheath blight of rice disease | |
Thaning et al. | Suppression of Sclerotinia sclerotiorum apothecial formation by the soil bacterium Serratia plymuthica: identification of a chlorinated macrolide as one of the causal agents | |
El-Sayed et al. | Rhizospheric-derived Nocardiopsis alba BH35 as an effective biocontrol agent actinobacterium with antifungal and plant growth-promoting effects: in vitro studies | |
Levy et al. | Suppression of Septoria tritici and Puccinia recondita of wheat by an antibiotic‐producing fluorescent pseudomonad | |
KR100333039B1 (en) | Novel antagonistic strain Promicromonospora sp. KH-28 and proess for production of antifungal antibiotic therefrom | |
Bhosale et al. | Optimization and characterization of antifungal metabolite from a soil actinomycete Streptomyces indiaensis SRT1 | |
KR100477890B1 (en) | A new Streptomyces sp. 8E12 and its use as a herbicidal agent | |
Sarode et al. | Screening for siderophore producing PGPR from black cotton soils of North Maharashtra | |
Ram et al. | Isolation of potential anti-microbial compounds from actinomycetes found in soil surrounding medicinal plants of Saurashtra, Gujarat, India | |
KR100327510B1 (en) | Antifungal activity and Preparation-method of antibiotics produced from Micromonospora coerulea Ao58 | |
US5279829A (en) | Fungicidal antibiotic from Streptomyces NCIMB 40212 | |
Kamalakannan et al. | Isolation and screening of endophytic actinomycetes producing antibacterial compound from different parts of Citrus aurantifolia | |
Biswas et al. | Isolation and characterization of Streptomyces sp. ANBS-15 and antimicrobial activities of its secondary metabolites | |
T Abdulhameed | The isolation and study of morphological characterization of Streptomyces isolated from the soil as a source of active antibiotic | |
Nisha et al. | In Vitro Study on Actinomycetes Extracts Against the Stem Bleeding Disease of Coconut | |
KR100245514B1 (en) | Streptomyces sp. producing antifungal agent and insecticide and biopesticide comprising culture thereof | |
Abou-Dobara et al. | Isolation and Screening of some Actinomycetes from Soil from Damietta and Mansoura and its Antimicrobial Activities | |
Kannan et al. | Screening and characterization of antimicrobial compound produced from selected marine actinomycte | |
Najm et al. | Evaluation of Antimicrobial-producing Actinomycetes Isolated from Regions in Baghdad City. | |
Neha et al. | Isolation and Screening of Potent Antibiotic-Producing Actinomycete | |
KR100396301B1 (en) | Antifungal activity and preparation-method of antibiotics produced from Actinomadura roseola Da2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120330 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |